Covington Capital Management’s Quest Diagnostics DGX Stock Holding History
Bought
Maintained
Sold
Other funds holding DGX
Covington Capital Management's DGX Position: Q3 2022 in Review
Covington Capital Management held its Quest Diagnostics (DGX) position steady in Q3 2022 at 119 shares worth $15K. The position accounts for ﹤0.01% of the portfolio, ranked #755.
Covington Capital Management first reported a position in DGX in Q4 2014 and has held it in 28 quarters since. The position peaked at $297K in Q2 2016. 809 funds tracked by Wall St. Rank hold DGX as of Q3 2022.
- Covington Capital Management held 119 shares of Quest Diagnostics worth $15K as of Q3 2022.
- Covington Capital Management left its Quest Diagnostics share count unchanged in Q3 2022.
- Quest Diagnostics made up ﹤0.01% of Covington Capital Management's portfolio in Q3 2022, its #755 holding.
- Covington Capital Management first reported a position in Quest Diagnostics in Q4 2014 and has held it in 28 quarters since.
- Covington Capital Management's Quest Diagnostics position peaked at $297K in Q2 2016.
- 809 funds tracked by Wall St. Rank held Quest Diagnostics as of Q3 2022.
Based on Covington Capital Management's 13F filing for Q3 2022, filed 15 Nov 2022.